Hashimoto M - Search Results

1

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.

Waragai M, Wei J, Fujita M, Nakai M, Ho GJ, Masliah E, Akatsu H, Yamada T, Hashimoto M. Waragai M, et al. Among authors: hashimoto m. Biochem Biophys Res Commun. 2006 Jul 7;345(3):967-72. doi: 10.1016/j.bbrc.2006.05.011. Epub 2006 May 11. Biochem Biophys Res Commun. 2006. PMID: 16707095

2

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.

Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E. Hashimoto M, et al. J Biol Chem. 2002 Mar 29;277(13):11465-72. doi: 10.1074/jbc.M111428200. Epub 2002 Jan 14. J Biol Chem. 2002. PMID: 11790792 Free article.

3

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Windisch M, Hutter-Paier B, Rockenstein E, Hashimoto M, Mallory M, Masliah E. Windisch M, et al. Among authors: hashimoto m. J Mol Neurosci. 2002 Aug-Oct;19(1-2):63-9. doi: 10.1007/s12031-002-0012-8. J Mol Neurosci. 2002. PMID: 12212795

4

Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein.

Masliah E, Hashimoto M. Masliah E, et al. Among authors: hashimoto m. Neurotoxicology. 2002 Oct;23(4-5):461-8. doi: 10.1016/s0161-813x(02)00029-3. Neurotoxicology. 2002. PMID: 12428718 Review.

5

Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.

Hashimoto M, Takenouchi T, Rockenstein E, Masliah E. Hashimoto M, et al. J Neurochem. 2003 Jun;85(6):1468-79. doi: 10.1046/j.1471-4159.2003.01791.x. J Neurochem. 2003. PMID: 12787066 Free article.

6

Transgenic models of alpha-synuclein pathology: past, present, and future.

Hashimoto M, Rockenstein E, Masliah E. Hashimoto M, et al. Ann N Y Acad Sci. 2003 Jun;991:171-88. Ann N Y Acad Sci. 2003. PMID: 12846986 Review.

7

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.

Hashimoto M, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21. Neuromolecular Med. 2003. PMID: 14528050 Review.

8

Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.

Hashimoto M, Masliah E. Hashimoto M, et al. Neurochem Res. 2003 Nov;28(11):1743-56. doi: 10.1023/a:1026073324672. Neurochem Res. 2003. PMID: 14584828 Review.

9

Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.

Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. J Biol Chem. 2004 May 28;279(22):23622-9. doi: 10.1074/jbc.M313784200. Epub 2004 Mar 16. J Biol Chem. 2004. PMID: 15026413 Free article.

10

The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.

Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. J Mol Neurosci. 2004;24(3):343-52. doi: 10.1385/JMN:24:3:343. J Mol Neurosci. 2004. PMID: 15655259 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,720 results

Search Page

Filters